3 Nuclear Stocks With Real Revenue vs. 3 That Are Still Pre-Revenue. Here’s Where the Money Actually Is.
If you care where nuclear money is flowing today, it helps to separate companies that already sell lots of electricity, hardware, and fuel from those that are still living on hope and capital raises. The gap between the two groups is wide, and it matters for anyone with a clear head trying to invest in the sector.
3 nuclear stocks with real revenue
Start with Constellation Energy (CEG +1.39%). This is one of the largest nuclear operators in the United States, and its numbers look like a mature utility. In the second quarter of 2026, Constellation reported operating revenues of $7.5 billion, GAAP (generally accepted accounting principles) net income of $513 million, and adjusted operating earnings of $920 million, or $2.55 per share.
Its nuclear fleet produced about 40 to 44 terawatt-hours of electricity in that quarter, at a 93% capacity factor, despite six planned refueling outages. That is real, contracted revenue from plants that run most of the time and sell power into markets that need carbon-free baseload and support for data centers and industry.
Today’s Change
(1.39%) $3.86
Current Price
$282.50
Key Data Points
Market Cap
Day’s Range
$280.67 – $287.00
52wk Range
$228.63 – $412.70
Volume
2M
Avg Vol
3.5M
Gross Margin
17.37%
Dividend Yield
0.58%
Next is BWX Technologies (BWXT +1.69%). BWX does not run reactors. It builds the parts that go inside them and the fuel that keeps them running. In 2025, consolidated revenue rose 18% to $3.2 billion. Government operations revenue reached about $2.35 billion, driven by higher production of naval nuclear components and special materials processing for the U.S. Navy.
Commercial operations revenue grew 63% to $853 million on stronger sales of commercial nuclear components, field services, fuel, and medical products. BWX’s business model is tied to long-term defense contracts and life-extension work at nuclear plants, which give it a steady backlog and visibility that many pure-play reactor start-ups lack.
Today’s Change
(1.69%) $2.87
Current Price
$173.22
Key Data Points
Market Cap
Day’s Range
$169.50 – $173.50
52wk Range
$157.10 – $241.82
Volume
537.7K
Avg Vol
949.2K
Gross Margin
22.07%
Dividend Yield
0.60%
Cameco (CCJ -0.01%) is a Canadian uranium producer that sits near the base of the nuclear fuel chain. Cameco’s annual revenue for 2025 was about $2.49 billion, up nearly 9% from 2024, and trailing-12-month revenue through mid 2025 was about $2.57 billion, up more than 31% year over year.
Recent quarters have seen revenue of around $634 million, with the uranium segment generating earnings before taxes of 170 million Canadian dollars ($123 million) and adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) of CA$252 million. Utilities and fuel buyers need uranium. Cameco earns money by selling it under long-term contracts that span years and often lock in price floors and ceilings.
Today’s Change
(-0.01%) $-0.01
Current Price
$97.74
Key Data Points
Market Cap
Day’s Range
$97.40 – $99.74
52wk Range
$68.96 – $135.24
Volume
2.2M
Avg Vol
3.4M
Gross Margin
25.62%
Dividend Yield
0.18%
3 stocks that are still waiting for revenue
On the other side of the nuclear hype are companies that get plenty of attention but still bring in little or no meaningful revenue. NuScale Power (SMR -4.67%) booked only about $100,000 of revenue in Q2 2026, down from $8.1 million a year earlier, and is burning hundreds of millions of dollars in cash while it waits for a utility or industrial partner to sign a binding deal to actually build and run its small modular reactors.
Oklo (OKLO -4.46%) looks a bit closer to turning the corner, with about $1.2 million in revenue last quarter. And some are modeling just $3.8 million in first commercial revenue in 2026 before any real reactor income arrives.
Image source: Getty Images.
Nano Nuclear Energy (NNE -4.19%) is earlier still, with no commercial deployments, growing losses, and a business that is, for now, mostly about getting microreactors licensed rather than selling power, which is why cash runway and dilution sit at the center of most investor conversations about it.
Where the money actually is
Nuclear headlines often focus on futuristic reactor designs and bold promises. The money right now sits with operators like the three I discussed earlier: Constellation, which sells electrons; manufacturers like BWX, which supply components and fuel; and miners like Cameco, which keep the fuel cycle stocked.
The pre-revenue firms might become important over the next decade, but their path involves regulatory hurdles and to-be-determined financing deals and execution risks that can stretch for years. If you want exposure to nuclear with less guesswork, it makes sense to start with businesses that already generate revenue and cash from nuclear technology, then size any bets on new and emerging designs.
